Clinical Trial Update: Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial comparing bulk versus fractionated stem cell infusions in patients with leukemia undergoing stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-12-29